These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1. Mode of action of Li in treating affective disorders-neurobiological considerations. Murphy DL; Costa JL; Bunney WE Neurosci Res Program Bull; 1976 Apr; 14(2):183-6. PubMed ID: 5691 [No Abstract] [Full Text] [Related]
2. Neurobiological Considerations of the mode of action of lithium carbonate in the treatment of affective disorders? Bunney WE; Murphy DL Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):142-7. PubMed ID: 185630 [TBL] [Abstract][Full Text] [Related]
3. [The neurobiology of lithium]. Navón S Medicina (B Aires); 1978; 38(1):93-104. PubMed ID: 30878 [No Abstract] [Full Text] [Related]
4. Plasma and erythrocyte kinetic considerations in lithium therapy. Nelson RW; Cohen JL Am J Hosp Pharm; 1976 Jul; 33(7):658-64. PubMed ID: 941922 [TBL] [Abstract][Full Text] [Related]
5. The effect of lithium on red blood cell cholinesterase activity in patients with affective disorders. Fieve RR; Milstoc M; Kumbaraci T; Dunner DL Dis Nerv Syst; 1976 May; 37(5):240-3. PubMed ID: 1261342 [No Abstract] [Full Text] [Related]
8. Lithium-responsive affective disorders. Model comprehensive plan for treatment. Daly RM N Y State J Med; 1978 Mar; 78(4):594-601. PubMed ID: 273749 [No Abstract] [Full Text] [Related]
9. Biochemical aspects of lithium in affective disorders. Platman SR; Fieve RR Arch Gen Psychiatry; 1968 Dec; 19(6):659-63. PubMed ID: 5697633 [No Abstract] [Full Text] [Related]
10. Lithium in affective disorders. Scardino J N Y State J Med; 1970 Mar; 70(5):638-42. PubMed ID: 4907068 [No Abstract] [Full Text] [Related]
11. [Neuromediators and anhedonia]. Ammar S Encephale; 1998 Jul; 24 Spec No 1():31-3. PubMed ID: 9809252 [No Abstract] [Full Text] [Related]
12. Neurobiologocal mechanisms of presynaptic metabolic adaptation and their organization: implications for a pathophysiology of the affective disorders. Mandell AJ Adv Biochem Psychopharmacol; 1975; 13():1-32. PubMed ID: 240255 [No Abstract] [Full Text] [Related]
13. Pharmacogenetic aspects of the lithium treatment of primary affective disorders. Zvolský P; Vinarová E; Dostál T; Soucek K; Krulík R Agressologie; 1978; 19(D):215-7. PubMed ID: 751511 [No Abstract] [Full Text] [Related]
14. Lithium in treatment and prevention of affective disorders. Jones GL; Estrada SD J Med Soc N J; 1972 Sep; 69(9):737-9. PubMed ID: 4506624 [No Abstract] [Full Text] [Related]
15. [Lithium valproate: its neuropharmacological spectrum and effect on transmitter amino acid content of the brain of rats]. Kharlamov AN; Shumkova OV; Blinkova NF; Tolmacheva NS; Raevskiĭ KS Farmakol Toksikol; 1984; 47(5):11-5. PubMed ID: 6149951 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic lithium in recurrent affective disorders: a four year study. Melia PI J Ir Med Assoc; 1970 Oct; 63(400):353-7. PubMed ID: 5505643 [No Abstract] [Full Text] [Related]
17. [Long term lithium treatment of affective disorders. Long term effects and side effects]. Hofmann G; Grünberger J; König P; Presslich O; Wolf R Psychiatr Clin (Basel); 1974; 7(3):129-48. PubMed ID: 4464541 [No Abstract] [Full Text] [Related]
18. Lithium carbonate prophylaxis in affective disorders. (Clinical versus research applications). Polatin P Dis Nerv Syst; 1972 Jul; 33(7):472-5. PubMed ID: 4648449 [No Abstract] [Full Text] [Related]
19. Lithium and rubidium: a role in the affective disorders. Platman SR Dis Nerv Syst; 1971 Sep; 32(9):604-6. PubMed ID: 5000097 [No Abstract] [Full Text] [Related]
20. [Experience with the use of lithium salts in the treatment of chronic alcoholism]. Ivanets NN; Rudenko GM; Igonin AL; Nebarakova TP Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(8):1237-41. PubMed ID: 899542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]